ES556685A0 - Un procedimiento para preparar tioesteroides sustituidos en posicion 21 - Google Patents

Un procedimiento para preparar tioesteroides sustituidos en posicion 21

Info

Publication number
ES556685A0
ES556685A0 ES556685A ES556685A ES556685A0 ES 556685 A0 ES556685 A0 ES 556685A0 ES 556685 A ES556685 A ES 556685A ES 556685 A ES556685 A ES 556685A ES 556685 A0 ES556685 A0 ES 556685A0
Authority
ES
Spain
Prior art keywords
sup
group
carbon atoms
thyosteroids
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES556685A
Other languages
English (en)
Other versions
ES8707256A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of ES556685A0 publication Critical patent/ES556685A0/es
Publication of ES8707256A1 publication Critical patent/ES8707256A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Dowels (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Compounds Of Unknown Constitution (AREA)
ES556685A 1985-06-26 1986-06-25 Un procedimiento para preparar tioesteroides sustituidos en posicion 21 Expired ES8707256A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13927685 1985-06-26

Publications (2)

Publication Number Publication Date
ES556685A0 true ES556685A0 (es) 1987-07-16
ES8707256A1 ES8707256A1 (es) 1987-07-16

Family

ID=15241512

Family Applications (1)

Application Number Title Priority Date Filing Date
ES556685A Expired ES8707256A1 (es) 1985-06-26 1986-06-25 Un procedimiento para preparar tioesteroides sustituidos en posicion 21

Country Status (6)

Country Link
US (1) US4861765A (es)
EP (1) EP0208202B1 (es)
JP (1) JPH0699468B2 (es)
AT (1) ATE42306T1 (es)
DE (1) DE3662896D1 (es)
ES (1) ES8707256A1 (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5439901A (en) * 1993-07-23 1995-08-08 The Procter & Gamble Company Cyproterone thiopivalate
US5344651A (en) * 1993-07-23 1994-09-06 The Procter & Gamble Company Cyproterone acetate thioacetate
US5420120A (en) * 1993-12-17 1995-05-30 Alcon Laboratories, Inc. Anti-inflammatory glucocorticoid compounds for topical ophthalmic use
ATE473759T1 (de) 1998-05-22 2010-07-15 Univ Leland Stanford Junior Bifunktionelle moleküle sowie darauf basierende therapien.
US6777400B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858593B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
EP2067784A3 (en) * 2000-08-05 2012-08-22 Glaxo Group Limited 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivatives as anti-inflammatory agents
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6787532B2 (en) * 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
US6750210B2 (en) * 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
US6777399B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
WO2002088167A1 (en) * 2001-04-30 2002-11-07 Glaxo Group Limited Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) * 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US7732432B2 (en) 2003-01-21 2010-06-08 Merck Sharp & Dohme Corp. 17-carbamoyloxy cortisol derivatives as selective glucocorticoid receptor modulators
US7435757B2 (en) * 2004-07-02 2008-10-14 Schering Ag 2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
CN102379684B (zh) 2005-04-28 2014-11-19 普罗透斯数字保健公司 药物信息系统
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
AR069804A1 (es) * 2007-12-21 2010-02-17 Schering Corp Agonistas del receptor glucocorticoide c20- c21 sustituido
CL2008003802A1 (es) * 2007-12-21 2010-02-19 Schering Corp Compuestos derivados de tioeteres c-21, agonistas del receptor de glucocorticoide; composicion farmaceutica; y uso para el tratamiento o profilaxis de una enfermedad o afeccion inmune, autoinmune o inflamatoria, tales como artritis reumatoide y esclerosis multiple.
EP2398500B1 (en) 2009-02-20 2019-03-13 2-BBB Medicines B.V. Glutathione-based drug delivery system
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
EP2443134A2 (en) 2009-06-16 2012-04-25 Schering Corporation NOVEL [3,2-c]HETEROARYL STEROIDS AS GLUCOCORTICOID RECEPTOR AGONISTS, COMPOSITIONS AND USES THEREOF

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3028400A (en) * 1962-04-03 Nsw steroid thioethers and process
US3105083A (en) * 1960-04-14 1963-09-24 Upjohn Co 21-organic sulfonates of 11, 17, 21-trioxygenated-3-keto pregnenes
US3171844A (en) * 1963-05-24 1965-03-02 Syntex Corp 20-(aliphatic hydrocarbonthio) and 20-(substituted aliphatic hydrocarbonthio) pregnane derivatives
FR2231374B1 (es) * 1973-05-30 1976-10-22 Jouveinal Sa
BE887518A (fr) * 1980-02-15 1981-08-13 Glaxo Group Ltd Cartothioates d'androstanes
FR2510582B1 (fr) * 1981-07-30 1986-05-30 Sipsy Steroides esterifies en la position 17 et thio-esterifies en la position 21, leur procede de preparation et leur application comme medicament
FR2551069B1 (fr) * 1983-08-26 1986-07-25 Jouveinal Sa 17-oxo-21-thioesters d'hydrocortisone, leur preparation et leurs applications comme medicament
US4488995A (en) * 1984-02-06 1984-12-18 E. R. Squibb & Sons, Inc. Androstene-17β-alkylthiomethyl ethers

Also Published As

Publication number Publication date
JPH0699468B2 (ja) 1994-12-07
DE3662896D1 (en) 1989-05-24
EP0208202B1 (en) 1989-04-19
JPS6289694A (ja) 1987-04-24
ATE42306T1 (de) 1989-05-15
EP0208202A1 (en) 1987-01-14
US4861765A (en) 1989-08-29
ES8707256A1 (es) 1987-07-16

Similar Documents

Publication Publication Date Title
DE3662896D1 (en) 21-substituted thiosteroids
ES545250A0 (es) Un procedimiento para preparar derivados de 1,8-naftiridina
ES8604547A1 (es) Procedimiento para preparar nuevos derivados de acidos feni-laceticos
AR241531A1 (es) Un procedimiento para la preparacion derivados de 2-indolinona, y sus sales farmaceuticamente aceptables.
ES460040A1 (es) Un procedimiento para preparar derivados de 4-hidroxifeni- lalcanolaminas.
IE851205L (en) Beta-carbolines
KR850004492A (ko) 옥시캄의 엔올 에테르 유도체의 제조방법
EP0191496A3 (en) Triazine derivatives, a process for preparing the derivatives, and herbicides containing the derivatives as the effective component
ES511753A0 (es) Un procedimiento para la preparacion de derivados de sucrosa'4-halo-sustituidos.
ES8306765A1 (es) "un procedimiento para preparar un derivado de antraciclina".
ES535899A0 (es) Un procedimiento para la preparacion de nuevos derivados de aminoalcoholes.
ES8801669A1 (es) Un procedimiento para preparar nuevos compuestos de 2-oxa-0 aza-pregnano.
GB2182328B (en) Diphenyl ether derivatives
NO901176L (no) Fremgangsmaate for fremstilling av 2,5,6,7-tetranor-4,8-inter-m-fenylen pgi2-derivater.
DE3569380D1 (en) Pyridylphenylpyridazinone inotropic agents
ATE21902T1 (de) 6-substituierte tetrahydroimidazo(2,1a)phthalazine.
ES553166A0 (es) Un procedimiento para preparar un derivado de carbaciclina
ES2032838T3 (es) Un procedimiento para preparar derivados tetrahidropirido (1,2-a)indol.
DE3564937D1 (en) Novel substituted phenyl ethers, process for their preparation, and their use in the preparation of substituted phenols
HUT38948A (en) Process for preparing new isoxazolo-quinolinone derivatives and pharmaceutical compositions containing such compounds
ES8600760A1 (es) Procedimiento para preparar 2-((3, 4-metilendioxi)-fenetil)-5-((3-carboxamido-4-hidroxi)- -hidroxibencil)-pirrolidina
ATE28628T1 (de) Phenylethylaminderivate und ihre zwischenprodukte.
ES8702877A1 (es) Un metodo para producir un derivado de acido benzoico.
DK504788A (da) Fremgangsmaade til fremstilling af makrolidforbindelser
IT8204804V0 (it) Tavolino ad ingombro riducibile, particolarmente adatto come piano di lavoro per l'esecuzione di piccole operazioni di saldatura

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970701